New HPTLC Chapter Proposed for The International Pharmacopoeia
Recommendation
20/21 January 2027
Ensuring Control of Chromatographs, Integration and Results
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The World Health Organization (WHO) has published a draft proposal for a new general chapter "1.18 High-Performance Thin-Layer Chromatography" (HPTLC) to be included in The International Pharmacopoeia.
According to the chapter’s introduction, HPTLC is a chromatographic technique "in which variables are controlled within narrow ranges, using a standardized methodology and appropriate equipment, in order to achieve more reproducible results compared to traditional thin-layer chromatography (TLC)."
The chapter includes:
- An introduction to HPTLC principles
- Required equipment and materials
- A step-by-step analytical procedure
- System suitability criteria and documentation standards
- A new reagent specification (saturated MgCl2 solution)
The draft is currently open for public consultation. Comments can be submitted via the WHO PleaseReview™ platform until 09 September 2025.
The proposed chapter is available on the WHO website under “Working documents in public consultation”.
Related GMP News
05.11.2026Eurachem Publishes Webinar Recording on the Fitness for Purpose of Analytical Methods Guide
05.11.2026Recent Publications Highlighting Topics to be Discussed at PharmaLab 2026
05.11.2026Meet the AQCG Board Members at PharmaLab 2026
05.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts